IBB

iShares Biotechnology ETF · NAS

  • Category Health Care
  • Expense Ratio 0.45%
  • Listing Date Feb 09, 2001
  • Volume 989,404.0
  • Market Cap (AUM) $6,092.23M

Performance

-1.48%

1W

-2.08%

1M

-1.73%

3M

-9.05%

6M

+1.5%

YTD

-0.85%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Amgen Inc.AMGN9.23%
  • Vertex Pharmaceuticals IncorporatedVRTX9.17%
  • Regeneron Pharmaceuticals, Inc.REGN8.88%
  • Gilead Sciences, Inc.GILD7.24%
  • Moderna, Inc.MRNA4.49%
  • IQVIA Holdings IncIQV3.84%
  • Biogen Inc.BIIB3.24%
  • Mettler-Toledo International Inc.MTD3.15%
  • Alnylam Pharmaceuticals, IncALNY1.94%
  • argenx SE ADRARGX1.91%

Technical Analysis of IBB 2025-03-14

The stock indicators suggest a bearish sentiment overall, with a Moving Average Score of 0 indicating strong negative momentum, while the Oscillators Score of 50 reflects a neutral stance, and the Technical Score of 25 reinforces the bearish outlook. This combination implies that the stock is currently facing downward pressure, with limited bull...
Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

See more ...

Recent News & Updates

Disclaimer: The information provided here and on kavout.com is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout makes no recommendations regarding investment decisions based on this information. You are solely responsible for your investments. Please conduct your own research and consult qualified financial advisors before investing. Past performance does not guarantee future results.